These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 24504806)

  • 1. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
    Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
    Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-23 is required for protection against systemic infection with Listeria monocytogenes.
    Meeks KD; Sieve AN; Kolls JK; Ghilardi N; Berg RE
    J Immunol; 2009 Dec; 183(12):8026-34. PubMed ID: 19923464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells.
    Cornelissen F; Mus AM; Asmawidjaja PS; van Hamburg JP; Tocker J; Lubberts E
    Arthritis Res Ther; 2009; 11(6):R194. PubMed ID: 20017902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells.
    Liu G; Guo J; Liu J; Wang Z; Liang D
    Clin Immunol; 2014 Oct; 154(2):127-40. PubMed ID: 25076485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites.
    Pineda MA; McGrath MA; Smith PC; Al-Riyami L; Rzepecka J; Gracie JA; Harnett W; Harnett MM
    Arthritis Rheum; 2012 Oct; 64(10):3168-78. PubMed ID: 22729944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen-induced arthritis by the chemokine receptor CXCR6.
    Slauenwhite D; Gebremeskel S; Doucette CD; Hoskin DW; Johnston B
    Arthritis Rheumatol; 2014 Nov; 66(11):3001-12. PubMed ID: 25132679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis.
    Marijnissen RJ; Roeleveld DM; Young D; Nickerson-Nutter C; Abdollahi-Roodsaz S; Garcia de Aquino S; van de Loo FA; van Spriel AB; Boots AM; van den Berg WB; Koenders MI
    Arthritis Rheumatol; 2014 Apr; 66(4):886-95. PubMed ID: 24757141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model.
    Wang R; Hasnain SZ; Tong H; Das I; Che-Hao Chen A; Oancea I; Proctor M; Florin TH; Eri RD; McGuckin MA
    Inflamm Bowel Dis; 2015 May; 21(5):973-84. PubMed ID: 25803508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities.
    Rickel EA; Siegel LA; Yoon BR; Rottman JB; Kugler DG; Swart DA; Anders PM; Tocker JE; Comeau MR; Budelsky AL
    J Immunol; 2008 Sep; 181(6):4299-310. PubMed ID: 18768888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis.
    Ghali JR; O'Sullivan KM; Eggenhuizen PJ; Holdsworth SR; Kitching AR
    Nephron; 2017; 135(3):207-223. PubMed ID: 27941331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated experimental arthritis in IL-33 deficient mice.
    Talabot-Ayer D; Martin P; Seemayer CA; Vigne S; Lamacchia C; Finckh A; Saiji E; Gabay C; Palmer G
    Cytokine; 2014 Sep; 69(1):68-74. PubMed ID: 25022964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.